233 related articles for article (PubMed ID: 16870508)
1. Epigenetic regulation of MHC-II and CIITA genes.
Wright KL; Ting JP
Trends Immunol; 2006 Sep; 27(9):405-12. PubMed ID: 16870508
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes.
Zika E; Ting JP
Curr Opin Immunol; 2005 Feb; 17(1):58-64. PubMed ID: 15653312
[TBL] [Abstract][Full Text] [Related]
3. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
4. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W
Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
6. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
[TBL] [Abstract][Full Text] [Related]
7. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
[TBL] [Abstract][Full Text] [Related]
8. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of MHC2TA transcription in cancer.
Holling TM; van Eggermond MC; Jager MJ; van den Elsen PJ
Biochem Pharmacol; 2006 Nov; 72(11):1570-6. PubMed ID: 16879803
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
[TBL] [Abstract][Full Text] [Related]
14. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
van der Stoep N; Quinten E; Alblas G; Plancke A; van Eggermond MC; Holling TM; van den Elsen PJ
Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
[TBL] [Abstract][Full Text] [Related]
15. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of CIITA transcriptional function by ubiquitin.
Greer SF; Zika E; Conti B; Zhu XS; Ting JP
Nat Immunol; 2003 Nov; 4(11):1074-82. PubMed ID: 14528304
[TBL] [Abstract][Full Text] [Related]
17. Regulation of MHC class II gene expression by the class II transactivator.
Reith W; LeibundGut-Landmann S; Waldburger JM
Nat Rev Immunol; 2005 Oct; 5(10):793-806. PubMed ID: 16200082
[TBL] [Abstract][Full Text] [Related]
18. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection.
He Y; Zhao Y; Zhang S; Chen W; Lin S; Yang Q; Liu J; Yang Y; Jin Y; Liu M
J Clin Virol; 2006 Dec; 37(4):282-6. PubMed ID: 16996793
[TBL] [Abstract][Full Text] [Related]
19. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.
Krawczyk M; Reith W
Tissue Antigens; 2006 Mar; 67(3):183-97. PubMed ID: 16573555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
